E R Cox

Summary

Affiliation: Express Scripts
Country: USA

Publications

  1. ncbi Medicare beneficiaries' management of capped prescription benefits
    E R Cox
    Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
    Med Care 39:296-301. 2001
  2. ncbi Trends in the prevalence of chronic medication use in children: 2002-2005
    Emily R Cox
    Express Scripts, Inc, St Louis, Missouri, USA
    Pediatrics 122:e1053-61. 2008
  3. ncbi Impact of patient and plan design factors on switching to preferred statin therapy
    Emily R Cox
    Office of Evidence Based Pharmacy Benefit Design, Express Scripts, Inc, St Louis, MO 63121, USA
    Ann Pharmacother 41:1946-53. 2007
  4. ncbi Health plan member experience with point-of-service prescription step therapy
    Emily R Cox
    Express Scripts, Inc, 13900 Riverport Dr, Maryland Heights, MO 63043, USA
    J Manag Care Pharm 10:291-8. 2004
  5. ncbi Over-the-counter pain reliever and aspirin use within a sample of long-term cyclooxygenase 2 users
    Emily R Cox
    Express Scripts, Inc, Maryland Heights, MO 63043, USA
    Arch Intern Med 164:1243-6. 2004
  6. ncbi Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s)
    Emily R Cox
    Office of Research and Planning, Express Scripts, Inc, 13900 Riverport Drive, Maryland Heights, MO 63043, USA
    Am J Manag Care 9:785-94. 2003
  7. ncbi Prescribing COX-2s for patients new to cyclo-oxygenase inhibition therapy
    Emily R Cox
    Office of Research and Planning, Express Scripts, Inc, 13900 Riverport Drive, Maryland Heights, MO 63043, USA
    Am J Manag Care 9:735-42. 2003
  8. ncbi Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample
    Emily R Cox
    Office of Research and Development, Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
    Pediatrics 111:237-43. 2003
  9. ncbi Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate
    Douglas E Mager
    Express Scripts, Inc, Maryland Heights, MO 63043, USA com
    Am J Manag Care 13:347-52. 2007
  10. ncbi Lowering copayments: impact of simvastatin patent expiration on patient adherence
    Rebecca L Sedjo
    Office of Evidence Based Pharmacy Benefit Design, Express Scripts Inc, St Louis, MO 63121, USA
    Am J Manag Care 14:813-8. 2008

Detail Information

Publications13

  1. ncbi Medicare beneficiaries' management of capped prescription benefits
    E R Cox
    Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
    Med Care 39:296-301. 2001
    ..This type of coverage is found predominantly within private Medigap policies and Medicare+Choice plans offering prescription coverage...
  2. ncbi Trends in the prevalence of chronic medication use in children: 2002-2005
    Emily R Cox
    Express Scripts, Inc, St Louis, Missouri, USA
    Pediatrics 122:e1053-61. 2008
    ..Our goal was to estimate the quarterly prevalence of and evaluate trends for chronic medication use in children...
  3. ncbi Impact of patient and plan design factors on switching to preferred statin therapy
    Emily R Cox
    Office of Evidence Based Pharmacy Benefit Design, Express Scripts, Inc, St Louis, MO 63121, USA
    Ann Pharmacother 41:1946-53. 2007
    ..Changing formulary status is a common strategy to encourage greater use of lower-cost brand and generic drugs...
  4. ncbi Health plan member experience with point-of-service prescription step therapy
    Emily R Cox
    Express Scripts, Inc, 13900 Riverport Dr, Maryland Heights, MO 63043, USA
    J Manag Care Pharm 10:291-8. 2004
    ..To better understand health plan member experience with point-of-service prescription step-therapy edits and outcomes in terms of drug received...
  5. ncbi Over-the-counter pain reliever and aspirin use within a sample of long-term cyclooxygenase 2 users
    Emily R Cox
    Express Scripts, Inc, Maryland Heights, MO 63043, USA
    Arch Intern Med 164:1243-6. 2004
  6. ncbi Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s)
    Emily R Cox
    Office of Research and Planning, Express Scripts, Inc, 13900 Riverport Drive, Maryland Heights, MO 63043, USA
    Am J Manag Care 9:785-94. 2003
    ..To verify the gastroprotective agent (GPA) rate assumption used in cost-effectiveness models for cyclo-oxygenase 2 inhibitors (COX-2s) and to re-estimate model outcomes using GPA rates from actual practice...
  7. ncbi Prescribing COX-2s for patients new to cyclo-oxygenase inhibition therapy
    Emily R Cox
    Office of Research and Planning, Express Scripts, Inc, 13900 Riverport Drive, Maryland Heights, MO 63043, USA
    Am J Manag Care 9:735-42. 2003
    ..To profile the pattern of cyclo-oxygenase 2 inhibitor (COX-2) use, including length of therapy, medical conditions treated, and gastrointestinal (GI) risk profile of users...
  8. ncbi Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample
    Emily R Cox
    Office of Research and Development, Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
    Pediatrics 111:237-43. 2003
    ..The purpose of this study was to evaluate geographic variation in the prevalence of prescription stimulant use and predictors of use among a nationally representative, commercially insured population 5 to 14 years old...
  9. ncbi Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate
    Douglas E Mager
    Express Scripts, Inc, Maryland Heights, MO 63043, USA com
    Am J Manag Care 13:347-52. 2007
    ..To evaluate the relationship between generic and brand copayment differentials and generic fill rate (GFR)...
  10. ncbi Lowering copayments: impact of simvastatin patent expiration on patient adherence
    Rebecca L Sedjo
    Office of Evidence Based Pharmacy Benefit Design, Express Scripts Inc, St Louis, MO 63121, USA
    Am J Manag Care 14:813-8. 2008
    ..To assess the impact of a decrease in statin copayments on medication adherence and demand for statins...
  11. ncbi The influence of targeted education on medication persistence and generic substitution among consumer-directed health care enrollees
    Rebecca L Sedjo
    Office of Evidence Based Pharmacy Benefit Design, Express Scripts Inc, One Express Way, St Louis, MO 63121, USA
    Health Serv Res 44:2079-92. 2009
    ..To evaluate an educational outreach among consumer-directed health plan (CDHP) enrollees on medication persistence and lower-cost generic substitution within four chronic medication therapies...
  12. ncbi Gender differences in self-reported symptom awareness and perceived ability to manage therapy with disease-modifying medication among commercially insured multiple sclerosis patients
    Anna Vlahiotis
    Express Scripts, Inc, 1 Express Way, St Louis, MO 63121, USA
    J Manag Care Pharm 16:206-16. 2010
    ..For both genders, use of disease-modifying medications (DMMs) in the clinical management of MS is pivotal in altering the natural course and diminishing progressive disability over time...
  13. ncbi Plan-sponsor savings and member experience with point-of-service prescription step therapy
    Brenda R Motheral
    Outcomes Research, Express Scripts. Inc, Maryland Heights, MO 63043, USA
    Am J Manag Care 10:457-64. 2004
    ..25; 95% CI, 0.08-0.80 vs OR, 0.12; 95% CI, 0.04-0.41). CONCLUSIONS: Step therapy produces significant drug savings. However, there appear to be opportunities to further members' and providers' understanding of these programs...